Anti Inflammatory Drugs Market Revenue, Trends, Analysis, and Forecast to 2032
The global anti-inflammatory drugs market size reached USD 111.42 Billion in 2021 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to latest analysis by Emergen Research. Potential pipeline candidates is the main factor driving the market revenue growth. For instance, the monoclonal antibody mirikizumab (LY3074828) fulfilled the primary and all significant secondary objectives in the LUCENT-1 ulcerative colitis Phase 3 study, according to a March announcement from Lilly. The drug's potential as a therapy for moderate to severe ulcerative colitis was assessed throughout the 12-week multicenter induction phase. The humanized monoclonal antibody attaches to the interleukin-23 p19 subunit (IL-23p19). A cytokine that promotes inflammation is interleukin-23. In March, Lilly bragged that the Phase 3 trial LUCENT-1, which used an anti-IL-23p19 monoclonal antibody, was the only one to show a reduction in bowel urgency in patients with moderate to severe ulcerative colitis. Mirikizumab can be used to treat ulcerative colitis and crohn's disease, according to Lilly.
The report provides a comprehensive analysis in an organized manner in the form of tables, graphs, charts, figures, and diagrams. The organized data paves the way for thorough examination and research of the current and future outlook of the market. The report further offers a thorough SWOT and Porter’s Five Forces analysis to impart a better understanding of the competitive landscape of the Anti Inflammatory Drugs market.
Download Free Exclusive Sample PDF @https://www.emergenresearch.com/request-sample/1299
Key companies operating in the Anti Inflammatory Drugs market include:
AbbVie Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Novartis AG, GSK plc, Lilly, Amgen Inc., Biogen
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Anti Inflammatory Drugs market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Key Benefits of the Report:
- Comprehensive analysis of the competitive scenario and its changing dynamics
- Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
- In-depth 8-year analysis of the Global Anti Inflammatory Drugs Market
- Critical understanding of the key market segments
- Comprehensive analysis of the drivers, restraints, trends, and opportunities
- Detailed regional analysis and extensive company profiling
- Extensive assessment of current and emerging trends of the market
For more informative information, please visit us @https://www.emergenresearch.com/industry-report/anti-inflammatory-drugs-market
Anti Inflammatory Drugs Market Segmentation:
-
Drug Class Outlook (Revenue, USD Billion; 2019-2030)
- Anti-Inflammatory Biologics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
-
Route of Administration Outlook (Revenue, USD Billion; 2019-2030)
- Oral
- Injection
- Inhalation
- Topical
-
Application Outlook (Revenue, USD Billion; 2019-2030)
- Autoimmune Inflammatory Diseases
- Rheumatoid Arthritis
- Psoriasis
- Others
- Respiratory Diseases
- Others
- Autoimmune Inflammatory Diseases
Anti Inflammatory Drugs Market Segmentation by Regions:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Click here to Get customization @https://www.emergenresearch.com/request-history/1299
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
More Related Reports By Emergen Research
- Anti Inflammatory Drugs Market Size
- Anti Inflammatory Drugs Market Share
- Anti Inflammatory Drugs Market Trends
- Anti Inflammatory Drugs Regional Market Demand
- Anti Inflammatory Drugs Market Analysis
- Anti Inflammatory Drugs Market Top Companies
- Anti Inflammatory Drugs Market News
- Anti Inflammatory Drugs Market Executive Summary
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Comments
Post a Comment